
COH34 analog 1
CAS No. 314248-24-3
COH34 analog 1( —— )
Catalog No. M32852 CAS No. 314248-24-3
COH34 analog 1 is a COH34 oxidation analogue that can be used to synthesize active compounds.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 65 | Get Quote |
![]() ![]() |
10MG | 104 | Get Quote |
![]() ![]() |
25MG | 210 | Get Quote |
![]() ![]() |
50MG | 342 | Get Quote |
![]() ![]() |
100MG | 537 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCOH34 analog 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCOH34 analog 1 is a COH34 oxidation analogue that can be used to synthesize active compounds.
-
DescriptionCOH34 analog 1, a metabolite, is an oxidized analog of COH34. COH34 is a potent poly(ADP-ribose) glycohydrolase (PARG) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number314248-24-3
-
Formula Weight325.38
-
Molecular FormulaC18H15NO3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (307.33 mM; Ultrasonic )
-
SMILESCc1ccc(cc1)S(=O)(=O)\N=C\c1c(O)ccc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chen SH, et al. Targeting dePARylation selectively suppresses DNA repair-defective and PARP inhibitor-resistant malignancies. Sci Adv. 2019 Apr 10;5(4):eaav4340.?
molnova catalog



related products
-
Compound C108
Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma.
-
MAGE-A3 195-203
This peptide MAGE-3-encoded HLA-A24 epitope is a high MHC binder.The identification of this MAGE-3/HLA-A24 peptide may as a result effectiveially offer the opportunities to design peptide-based immunotherapeutic approaches that might prove to be potent in treating patients with MAGE-3-positive malignant tumors.
-
Methylophiopogonanon...
Methylophiopogonanone A has anti-inflammatory and anti-oxidative properties.